2Metre R,Anne C,Lillian N,et al. Different levels of platelet activation in preeclamptic, normotensive pregnant, and nonpregnant women [J]. Am J Obstet Gynecol,2004,190 : 1128-1134.
3Ahlawat S, Pati HP, Bhatla N,et al. Plasma platelet aggregating factor and platelet aggregation studies in preeclampsia[J]. Acta Obstet Gynecol Scand, 1996,75 (5) :428-431.
4Francoise H, Mark A ,Timothy A,et al. Platelet activation in the hypertensive disorders of pregnancy [J]. Am J Obstet Gynecol,2002,187 ( 3 ) :688-695.
5loannis K,Sunil K,Eman A. Platelet activation in pregnancy-induced hypertension [J]. Thromb Res ,2005,116 ( 1 ) :377-383.
6Dadelszen P, Magee LA, Devarakonda RM,et al. The prediction of adverse maternal outcomes in preeclampsia [J]. J Obstet Gynaecol Can,2004. ,26(10) :871-879.
7Wang Y,Gu Y,Zhang Y,et al. Evidence of endothelial dysfunction in preeclampsia:decreased endothelial nitric oxide synathase expression is associated with increased cell permeability in endothelial cells from preeclampsia[ J ]. Am J Obstet Gynecol,2004,190:817-824.
8Joey P, Barbara T Maria T. Pathophysiology of hypertension during preeclampsia linking placental ischemia with endothelial dysfunction[J]. Hypertension, 2001,38(2) :718-722.
9Shu F, Sugimura M, Kanayama N,et al. Immunohistochemical study of annexin V expression in placentae of preeclampsia [J].Gynecol Obstet Invest, 2000,49( 1 ) :17-23.
10Jacob H, Harry A, Charles J, et al. Pregnancy loss in the antiphospholipid antibody syndrome a possible thrombogenic mechanism [J]. N Engl J Med , 1997,337 : 154-160.
